Back to results
US 5,492,895 AGranted
Inhibitors of thrombosis
AssigneeCorvas International, Inc.
InventorsGeorge P. Vlasuk, Thomas R. Webb, Daniel A. Pearson, Matthew M. Abelman
Life of this patent
Estimating the term…
Abstract
This invention relates to peptide aldehyde analogs that inhibit the thrombin or Factor Xa. The compounds are thought useful for preventing or treating conditions in mammal characterized by abnormal thrombosis.
Claims31
A compound of the formula:
- ##STR97## wherein (a) R.sub.1 is selected from the group consisting of
- (1) alkyl of about 5 to about 10 carbon atoms if X is --C(.dbd.O)-- or --O--C(.dbd.O)-- or alkyl of 1 to about 10 carbon atoms if X is --S(O.sub.2)--, --NH--S(O.sub.2)-- or --O--S(O.sub.2)--,
- (2) alkyl of 1 to about 3 carbon atoms substituted with cyclic alkyl of about 5 to about 8 carbon atoms,
- (3) alkenyl of about 3 to about 6 carbon atoms optionally substituted with cyclic alkyl of about 5 to about 8 carbon atoms,
- (4) aryl of about 6 to about 14 carbon atoms which is optionally mono-substituted with Y.sub.1 or optionally di-substituted with Y.sub.1 and Y.sub.2,
- (5) aralkyl of about 6 to about 15 carbon atoms which is optionally mono-substituted in the aryl ring with Y.sub.1 or optionally di-substituted in the aryl ring with Y.sub.1 and Y.sub.2,
- (6) aralkenyl of about 8 to about 15 carbon atoms which is optionally mono-substituted in the aryl ring with Y.sub.1 or optionally di-substituted in the aryl ring with Y.sub.1 and Y.sub.2,
- (7) perfluoroalkyl of 1 to about 12 carbon atoms,
- (8) perfluoroaryl of about 6 to about 14 carbon atoms,
- (9) trimethylsilylalkyl of 4 to about 8 carbon atoms, ##STR98## wherein Y.sub.1 and Y.sub.2 are independently selected from the group consisting of bromo, chloro, fluoro, Z.sub.1 --, HO--, Z.sub.1 --O--, NH.sub.2 --, Z.sub.1 --NH--, (Z.sub.1, Z.sub.2)N--, Z.sub.1 --C(O)--NH--, HS--, Z.sub.1 --S--, Z.sub.1 --S(O)--, Z.sub.1 --S(O.sub.2)--, HO--S(O.sub.2)--, Z.sub.1 --O--S(O.sub.2)--, NH.sub.2 --S(O.sub.2)-- and Z.sub.1 --NH--S(O.sub.2)--, wherein Z.sub.1 and Z.sub.2 are independently selected from the group consisting of trifluoromethyl, pentafluoroethyl, alkyl of 1 to about 12 carbon atoms, aryl of about 6 to about 14 carbon atoms, and aralkyl of about 6 to about 15 carbon atoms;
- (b) X is --C(.dbd.O)--, --O--C(.dbd.O)--, --S(O.sub.2)--, --NH--S(O.sub.2)--, --O--S(O.sub.2)--;
- (c) m is 1 or 2;
- (d) R.sub.2 is --CO.sub.2 H, --CO.sub.2 R', or ##STR99## wherein R' is alkyl of 1 to about 4 carbon atoms, aryl of about 6 to about 14 carbon atoms, aralkyl of about 6 to about 14 carbon atoms;
- and
- (e) R.sub.3 is --(CH.sub.2).sub.3 --NH--C(.dbd.NH)--NH.sub.2 ;
- or a pharmaceutically acceptable salt thereof.
13 more elements
Dependencies are inferred from the claim text.